Biocon Limited (BIOCON)
BSE
Closed
Oct 1, 2026
Day's Range
363.5552 wk Range
337.95Overview - BIOCON - Biocon Limited
Key Statistics
Valuation
Enterprise Value
742.08B
P/E (Trailing)
‪108.76‬
P/E (Forward)
‪34.08‬
PEG Ratio
‪0.46‬
Price / Sales (TTM)
‪3.50‬
Price / Book
‪1.76‬
EV / EBITDA
‪20.71‬
Profitability
Gross Margin
‪65.80%‬
Profit Margin
‪2.86%‬
Operating Margin
‪6.91%‬
Return on Assets
‪0.60%‬
Return on Equity
‪1.05%‬
Ownership
Shares Outstanding
1.63B
Float
806.22M
Held by Insiders
‪48.11%‬
Held by Institutions
‪30.54%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪407.02‬
200-Day Avg
‪395.02‬
Dividends
Payout Ratio
‪14.58%‬
Analyst Consensus
18 analysts
Average price target
‪₹ 446.89‬Market Cap - BIOCON - Biocon Limited
Peers - BIOCON - Biocon Limited
Peer Comparison
Compared with companies in Biotechnology listed on BSE.
Profile Summary - BIOCON - Biocon Limited
About
Biocon Limited is a biopharmaceutical company engaged in the research, development, and manufacturing of pharmaceutical products. The company is known for its focus on innovating affordable therapies for chronic conditions in areas like oncology, diabetes, and autoimmune diseases. A key aspect of Biocon's operations…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
